Christopher R. Fenimore - Feb 9, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Finance & CFO
Signature
/s/**Christopher R. Fenimore
Stock symbol
REGN
Transactions as of
Feb 9, 2024
Transactions value $
-$4,689,320
Form type
4
Date filed
2/12/2024, 04:02 PM
Previous filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock -Sell -$326,969 -344 -1.78% $950.49 18,947 Feb 9, 2024 Direct F1
transaction REGN Common Stock -Sell -$463,327 -487 -2.57% $951.39 18,460 Feb 9, 2024 Direct F2
transaction REGN Common Stock -Sell -$996,441 -1,046 -5.67% $952.62 17,414 Feb 9, 2024 Direct F3
transaction REGN Common Stock -Sell -$1,279,557 -1,342 -7.71% $953.47 16,072 Feb 9, 2024 Direct F4
transaction REGN Common Stock -Sell -$1,050,027 -1,100 -6.84% $954.57 14,972 Feb 9, 2024 Direct F5
transaction REGN Common Stock -Sell -$573,000 -600 -4.01% $955.00 14,372 Feb 9, 2024 Direct
holding REGN Common Stock 1,473 Feb 9, 2024 2021 GRAT
holding REGN Common Stock 4,269 Feb 9, 2024 2022 GRAT
holding REGN Common Stock 1,499 Feb 9, 2024 By 401(k) Plan
holding REGN Common Stock 1,897 Feb 9, 2024 By Trust F6
holding REGN Common Stock 461 Feb 9, 2024 by Trust for Daugh
holding REGN Common Stock 460 Feb 9, 2024 by Trust for Son

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 344 shares of Company stock on February 9, 2024 at prices ranging from $950.33 to $950.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F2 Represents volume-weighted average price of sales of 487 shares of Company stock on February 9, 2024 at prices ranging from $951.03 to $951.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 1,046 shares of Company stock on February 9, 2024 at prices ranging from $952.11 to $952.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 1,342 shares of Company stock on February 9, 2024 at prices ranging from $953.02 to $953.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 1,100 shares of Company stock on February 9, 2024 at prices ranging from $954.00 to $954.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.
F6 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.